Barclays’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-27,000
| Closed | -$4.18M | – | 5493 |
|
|
2025
Q4 | $4.18M | Hold |
27,000
| – | – | ﹤0.01% | 2351 |
|
|
2025
Q3 | $3.76M | Buy |
+27,000
| New | +$3.65M | ﹤0.01% | 2414 |
|
|
2024
Q4 | – | Sell |
-80,000
| Closed | -$12.3M | – | 5513 |
|
|
2024
Q3 | $12.3M | Buy |
+80,000
| New | +$12.1M | ﹤0.01% | 1331 |
|
|
2024
Q1 | – | Sell |
-30,000
| Closed | -$4.09M | – | 5413 |
|
|
2023
Q4 | $4.09M | Buy |
+30,000
| New | +$3.9M | ﹤0.01% | 2290 |
|
|
2022
Q1 | – | Sell |
-50,000
| Closed | -$7.04M | – | 5708 |
|
|
2021
Q4 | $7.04M | Hold |
50,000
| – | – | ﹤0.01% | 1479 |
|
|
2021
Q3 | $6.37M | Hold |
50,000
| – | – | ﹤0.01% | 1466 |
|
|
2021
Q2 | $6.3M | Sell |
50,000
-235,000
| -82% | -$28.8M | ﹤0.01% | 1461 |
|
|
2021
Q1 | $33.3M | Sell |
285,000
-222,000
| -44% | -$25.6M | 0.02% | 602 |
|
|
2020
Q4 | $57.5M | Buy |
507,000
+312,800
| +161% | +$34.1M | 0.03% | 419 |
|
|
2020
Q3 | $20.5M | Buy |
194,200
+185,700
| +2,185% | +$19.5M | 0.01% | 735 |
|
|
2020
Q2 | $851K | Sell |
8,500
-95,300
| -92% | -$9.41M | ﹤0.01% | 2900 |
|
|
2020
Q1 | $9.2M | Sell |
103,800
-210,000
| -67% | -$20.4M | 0.01% | 1037 |
|
|
2019
Q4 | $32M | Buy |
313,800
+147,100
| +88% | +$14.1M | 0.02% | 705 |
|
|
2019
Q3 | $15M | Buy |
166,700
+60,000
| +56% | +$5.48M | 0.01% | 1048 |
|
|
2019
Q2 | $9.88M | Sell |
106,700
-91,900
| -46% | -$8.26M | 0.01% | 1359 |
|
|
2019
Q1 | $18.2M | Sell |
198,600
-57,800
| -23% | -$5.21M | 0.01% | 901 |
|
|
2018
Q4 | $22.2M | Buy |
256,400
+213,200
| +494% | +$19.3M | 0.02% | 702 |
|
|
2018
Q3 | $4.11M | Sell |
43,200
-87,900
| -67% | -$7.94M | ﹤0.01% | 2009 |
|
|
2018
Q2 | $10.9M | Sell |
131,100
-59,400
| -31% | -$4.92M | 0.01% | 1163 |
|
|
2018
Q1 | $15.5M | Sell |
190,500
-116,700
| -38% | -$9.94M | 0.01% | 975 |
|
|
2017
Q4 | $25.4M | Sell |
307,200
-41,100
| -12% | -$3.39M | 0.02% | 683 |
|
|
2017
Q3 | $28.5M | Buy |
348,300
+196,000
| +129% | +$15.7M | 0.03% | 522 |
|
|
2017
Q2 | $12.1M | Sell |
152,300
-174,100
| -53% | -$13.3M | 0.01% | 861 |
|
|
2017
Q1 | $24.3M | Sell |
326,400
-200,200
| -38% | -$14.6M | 0.03% | 483 |
|
|
2016
Q4 | $36.3M | Buy |
526,600
+246,600
| +88% | +$17.1M | 0.04% | 357 |
|
|
2016
Q3 | $20.2M | Buy |
280,000
+84,000
| +43% | +$6.18M | 0.02% | 547 |
|
|
2016
Q2 | $14.1M | Sell |
196,000
-63,000
| -24% | -$4.44M | 0.02% | 672 |
|
|
2016
Q1 | $17.4M | Buy |
259,000
+124,000
| +92% | +$8.31M | 0.03% | 529 |
|
|
2015
Q4 | $9.72M | Sell |
135,000
-285,600
| -68% | -$20.2M | 0.01% | 904 |
|
|
2015
Q3 | $27.8M | Buy |
420,600
+85,400
| +25% | +$6.24M | 0.03% | 452 |
|
|
2015
Q2 | $24.8M | Buy |
335,200
+249,600
| +292% | +$18.5M | 0.03% | 552 |
|
|
2015
Q1 | $6.16M | Sell |
85,600
-707,800
| -89% | -$50.5M | 0.01% | 1405 |
|
|
2014
Q4 | $54M | Buy |
793,400
+731,500
| +1,182% | +$49M | 0.05% | 328 |
|
|
2014
Q3 | $3.9M | Sell |
61,900
-1,000
| -2% | -$62.6K | ﹤0.01% | 2023 |
|
|
2014
Q2 | $3.77M | Sell |
62,900
-102,800
| -62% | -$6.04M | ﹤0.01% | 2017 |
|
|
2014
Q1 | $9.61M | Sell |
165,700
-93,400
| -36% | -$5.38M | 0.01% | 1177 |
|
|
2013
Q4 | $14.3M | Buy |
259,100
+23,900
| +10% | +$1.28M | 0.01% | 996 |
|
|
2013
Q3 | $11.8M | Buy |
235,200
+10,600
| +5% | +$533K | 0.01% | 1027 |
|
|
2013
Q2 | $10.7M | Buy |
+224,600
| New | +$10.8M | 0.01% | 1036 |
|
Other funds holding XLV
Barclays's XLV Position: Q1 2026 in Review
Barclays increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 103% in Q1 2026, buying an estimated $152M and bringing the position to 1,947,906 shares worth $286M. The position accounts for 0.07% of the portfolio, ranked #208.
Barclays first reported a position in XLV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.56B in Q4 2021. 1,804 funds tracked by Wall St. Rank hold XLV as of Q1 2026.
- Barclays held 1,947,906 shares of State Street Health Care Select Sector SPDR ETF worth $286M as of Q1 2026.
- Barclays bought 987,912 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $152M.
- State Street Health Care Select Sector SPDR ETF made up 0.07% of Barclays's portfolio in Q1 2026, its #208 holding.
- Barclays first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and has held it in 52 quarters since.
- Barclays's State Street Health Care Select Sector SPDR ETF position peaked at $1.56B in Q4 2021.
- 1,804 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.